STOKE THERAPEUTICS
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for the treatment of severe genetic diseases.
STOKE THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2014-01-01
Address:
Bedford, Massachusetts, United States
Country:
United States
Website Url:
http://www.stoketherapeutics.com
Total Employee:
101+
Status:
Active
Contact:
781-430-8200
Email Addresses:
[email protected]
Total Funding:
235.1 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arvinas
Arvinas focuses on developing novel therapeutics to treat a variety of diseases including cancer, pro-inflammatory, and autoimmune.
Closed Loop Medicine
Developing personalised digital healthcare solutions to improve outcomes for patients and clinicians
Evolus
Evolus medical aesthetics focused on providing physicians and their patients with expanded choices in aesthetic procedures and treatments.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
Icosavax
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
Korro Bio
Korro Bio provides an efficient and selective method for RNA editing, leveraging natural processes common to all multi-cellular organisms.
Manifold Bio
Manifold Bio is building a protein barcoding platform to bring the power of multiplexed measurement.
Nodexus
Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.
Peptomyc
Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.
Pyxis Oncology
Pyxis Oncology is a developer of antibody therapeutics intended to promote the body's immune response to cancer.
Rubius Therapeutics
Rubius has developed the technology to grow, genetically engineer and mature long-circulating Red-Cell Therapeutics.
Seagen
Seagen is dedicated to improving patient outcomes with advanced antibody-drug conjugate technology.
Vaccitech
Vaccitech is creating novel vaccines that elicit strong responses from helper and cytotoxic T-cells.
Ventus Therapeutics
Ventus Therapeutics develops small molecule medicines that target innate immune protein structures.
Vibliome
Vibliome is developing a new family of therapeutics for the treatment of cancer, contraception and other indications.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Alexandria Venture Investments
Alexandria Venture Investments investment in Series B - Stoke Therapeutics
RA Capital Management
RA Capital Management investment in Series B - Stoke Therapeutics
RTW Investments LLC
RTW Investments LLC investment in Series B - Stoke Therapeutics
Sphera Funds Management
Sphera Funds Management investment in Series B - Stoke Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series B - Stoke Therapeutics
Apple Tree Partners
Apple Tree Partners investment in Series B - Stoke Therapeutics
Janus Henderson Investors
Janus Henderson Investors investment in Series B - Stoke Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Stoke Therapeutics
Redmile Group
Redmile Group investment in Series B - Stoke Therapeutics
Apple Tree Partners
Apple Tree Partners investment in Series A - Stoke Therapeutics
Official Site Inspections
http://www.stoketherapeutics.com Semrush global rank: 3.63 M Semrush visits lastest month: 3.93 K
- Host name: 50.195.42.173
- IP address: 50.195.42.173
- Location: Boston United States
- Latitude: 42.3498
- Longitude: -71.0765
- Metro Code: 506
- Timezone: America/New_York
- Postal: 02116
